Phase I Trial of Metabolic Reprogramming Therapy for Treatment of Recurrent Head and Neck Cancers
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to study the effect of the drug DCA (dichloroacetate) on
recurrent head and neck cancers. Part of this study will also use EF5 PET scan to study tumor
hypoxia.